Wordt geladen...
FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen
BACKGROUND: Genomic aberrations (mutations, gene fusions, amplifications) and dysregulation of the fibroblast growth factor (FGF) receptor (FGFR) signaling pathway are frequently found in squamous cell carcinomas of the head and neck (HNSCCs). Targeted therapy with tyrosine kinase inhibitors (TKIs)...
Bewaard in:
| Gepubliceerd in: | HNO |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Medizin
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902560/ https://ncbi.nlm.nih.gov/pubmed/32519203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00106-020-00893-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|